Developing “Nurse AMIE”: A tablet‐based supportive care intervention for women with metastatic breast cancer

Schmitz, Kathryn H.; Zhang, Xiaochen; Winkels, Renate M.; Schleicher, Erica; Mathis, Katlynn; Doerksen, Shawna E.; Cream, Leah; Rosenberg, Jennifer; Kass, Rena; Farnan, Michelle; Halpin-Murphy, Patricia; Suess, Robin; Zucker, David S.; Hayes, Michael

doi:10.1002/pon.5301

Cited by 11 publications

(10 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Table 2 outlines the characteristics of the included interventions and the engagement outcomes. The included studies had a sample size ranging from 6 [ 61 ] to 766 [ 31 ] and included multiple RCTs (16/39, 41%) [ 30 , 31 , 33 - 35 , 37 - 39 , 43 - 45 , 48 , 50 , 57 , 63 , 67 , 68 ], with most studies being conducted in the United States (22/39, 56%) [ 29 - 31 , 33 , 34 , 37 - 41 , 43 , 45 , 46 , 48 , 50 , 54 , 57 , 59 , 60 , 66 - 68 ]. Of the 39 studies included in the review, 13 (33%) explored intervention effects in the context of routine care implementation [ 29 , 32 , 36 , 41 , 42 , 49 , 51 , 52 , 58 , 60 - 62 , 64 ], with the remainder exploring intervention effects often using a blinded controlled trial design.…”

Section: Resultsmentioning

confidence: 99%

“…Table 2 outlines the characteristics of the included interventions and the engagement outcomes. The included studies had a sample size ranging from 6 [61] to 766 [31] and included multiple RCTs (16/39, 41%) [30,31,[33][34][35][37][38][39][43][44][45]48,50,57,63,67,68], with most studies being conducted in the United States (22/39, 56%) [29][30][31]33,34,[37][38][39][40][41]43,45,46,48,50,54,57,59,60,[66][67][68]. Of the 39 studies included in the review, 13 (33%) explored intervention effects in the context of routine care implementation [29,32,36,41,42,49,…”

Section: Study Characteristicsmentioning

confidence: 99%

Section: Durationmentioning

confidence: 99%

“…A total of 15% (6/39) of studies that had open-ended interventions reported the length of time that each participant was exposed to the intervention [43,52,[56][57][58][59]. A total of 10% (4/39) of studies reported the average time of exposure to the intervention, ranging from 62 to 195 days [43,52,57,59]. A total of 3% (1/39) of studies reported a median amount of exposure to the intervention of 6 months [58], and the final study (1/39, 3%) reported the number of participants exposed for >4 weeks (n=5) and >12 weeks (n=1) [56].…”

Section: Durationmentioning

confidence: 99%

See 3 more Smart Citations

The Extent of Engagement With Telehealth Approaches by Patients With Advanced Cancer: Systematic Review

Goodman¹,

Bagnall²,

Ashley³

et al. 2022

JMIR Cancer

View full text Add to dashboard Cite

Background Telehealth approaches are increasingly being used to support patients with advanced diseases, including cancer. Evidence suggests that telehealth is acceptable to most patients; however, the extent of and factors influencing patient engagement remain unclear. Objective The aim of this review is to characterize the extent of engagement with telehealth interventions in patients with advanced, incurable cancer reported in the international literature. Methods This systematic review was registered with PROSPERO (International Prospective Register of Systematic Reviews) and is reported in line with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 guidelines. A comprehensive search of databases was undertaken for telehealth interventions (communication between a patient with advanced cancer and their health professional via telehealth technologies), including MEDLINE, Embase, CINAHL, PsycINFO, Cochrane Library, Sociological Abstracts, and Web of Science, from the inception of each electronic database up until December 31, 2020. A narrative synthesis was conducted to outline the design, population, and context of the studies. A conceptual framework of digital engagement comprising quantitative behavioral measures (frequency, amount, duration, and depth of use) framed the analysis of engagement with telehealth approaches. Frequency data were transformed to a percentage (actual patient engagement as a proportion of intended engagement), and the interventions were characterized by intensity (high, medium, and low intended engagement) and mode of delivery for standardized comparisons across studies. Results Of the 19,676 identified papers, 40 (0.2%) papers covering 39 different studies were eligible for inclusion, dominated by US studies (22/39, 56%), with most being research studies (26/39, 67%). The most commonly reported measure of engagement was frequency (36/39, 92%), with substantial heterogeneity in the way in which it was measured. A standardized percentage of actual patient engagement was derived from 17 studies (17/39, 44%; n=1255), ranging from 51% to 100% with a weighted average of 75.4% (SD 15.8%). A directly proportional relationship was found between intervention intensity and actual patient engagement. Higher engagement occurred when a tablet, computer, or smartphone app was the mode of delivery. Conclusions Understanding engagement for people with advanced cancer can guide the development of telehealth approaches from their design to monitoring as part of routine care. With increasing telehealth use, the development of meaningful and context- and condition-appropriate measures of telehealth engagement is needed to address the current heterogeneity in reporting while improving the understanding of optimal implementation of telehealth for oncology and palliative care. Trial Registration PROSPERO (International Prospective Register of Systematic Reviews) CRD42018117232; https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42018117232

show abstract

Section: Resultsmentioning

confidence: 99%

“…Table 2 outlines the characteristics of the included interventions and the engagement outcomes. The included studies had a sample size ranging from 6 [61] to 766 [31] and included multiple RCTs (16/39, 41%) [30,31,[33][34][35][37][38][39][43][44][45]48,50,57,63,67,68], with most studies being conducted in the United States (22/39, 56%) [29][30][31]33,34,[37][38][39][40][41]43,45,46,48,50,54,57,59,60,[66][67][68]. Of the 39 studies included in the review, 13 (33%) explored intervention effects in the context of routine care implementation [29,32,36,41,42,49,…”

Section: Study Characteristicsmentioning

confidence: 99%

Section: Durationmentioning

confidence: 99%

Section: Durationmentioning

confidence: 99%

See 2 more Smart Citations

The Extent of Engagement With Telehealth Approaches by Patients With Advanced Cancer: Systematic Review

Goodman¹,

Bagnall²,

Ashley³

et al. 2022

JMIR Cancer

View full text Add to dashboard Cite

show abstract

“…Similar to [2], the authors of [11] integrated a voice interface into an existing IMI platform: Nurse AMIE [12]. The system supports women with metastatic breast cancer through a self-administered intervention solution that includes psychoeducation and mindfulness meditations.…”

Section: B Enabling Interventions For Vasmentioning

confidence: 99%

Generic Concept for Integrating Voice Assistance Into Smart Therapeutic Interventions

Scheible

Hofmann

Reichert

et al. 2022

2022 IEEE 35th International Symposium on Computer-Based Medical Systems (CBMS)

View full text Add to dashboard Cite

Therapeutic Interventions (TIs) play an important role in modern medical and psychological treatments, but their integration into the digital world still shows deficits, e.g., in the integration of the auditory interface. Initiatives to integrate this interface into existing Internet-and Mobile-Based Interventions (IMIs) are largely focused on a small group of Voice Assistants (VAs) and their specific capabilities. To mitigate these drawbacks, the presented concept seamlessly integrates arbitrary VAs into the treatment process of TIs. To this end, an architecture -including a discussion of relevant requirements -is presented that, on the one hand, uses VAs as the only point of contact with patients and, on the other hand, provides a comprehensive webbased backend for Healthcare Providers (HCPs). Based on the architecture, a proof-of-concept implementation using Amazon Alexa is presented. Finally, it is discussed that the scenario addressed and the solution presented have great potential, but still need a lot of work and technical considerations.

show abstract

Technology-based supportive care for metastatic breast cancer patients

Schmitz

Kanski

Gordon

et al. 2023

Support Care Cancer

Self Cite

View full text Add to dashboard Cite

Metastatic breast cancer (MBC) patients are living longer. However, symptom burden remains a signi cant issue.Technology-based interventions may be a solution. The purpose of this study was to test a virtual assistant for addressing symptoms in MBC using the Amazon Echo Show with Alexa. MethodsIn this partial crossover randomized trial, the immediate treatment group was exposed to the intervention, called Nurse AMIE (Addressing Metastatic Individuals Everyday) for six months. The comparison group was unexposed for the rst 3 months, then exposed for 3 months. The randomized controlled trial (RCT) during the rst 3 months allowed for evaluation of intervention effects on symptoms and function. The partial crossover maximized exposure to the intervention for evaluation of feasibility, usability, and satisfaction. RCT outcome data were collected at baseline and 3 months. Feasibility, usability, and satisfaction data were collected throughout the rst 3 months of intervention exposure. ResultsForty-two MBC patients were randomized (1:1). Participants were 53±11 years old and 4±7 years from diagnosis with metastatic disease. No signi cant effects on psychosocial distress, pain, sleep disturbance, fatigue (vitality), quality of life, or chair stands were noted, despite high levels of acceptability (51%), feasibility (65%), and satisfaction (70%). ConclusionA high level of participant acceptability, feasibility, usability, and satisfaction all suggest further research on this platform is warranted. The lack of statistically signi cant effects on symptoms, quality of life, and function may be the result of small sample size.

show abstract

Developing “Nurse AMIE”: A tablet‐based supportive care intervention for women with metastatic breast cancer

Abstract: Funding informationAvon Breast Cancer Crusade K E Y W O R D S : breast cancer, exercise, metastatic, mHealth, physical function, quality of life, technology-based interventions

Cited by 11 publications

References 10 publications

The Extent of Engagement With Telehealth Approaches by Patients With Advanced Cancer: Systematic Review

The Extent of Engagement With Telehealth Approaches by Patients With Advanced Cancer: Systematic Review

Generic Concept for Integrating Voice Assistance Into Smart Therapeutic Interventions

Technology-based supportive care for metastatic breast cancer patients

Contact Info

Product

Resources

About